EXPLORE THE SCIENCE
TL;DR: A 2026 systematic review and meta-analysis in International Journal of Obesity found that glucagon-like peptide-1 receptor agonists, metabolic drugs that extend a satiety and glucose-control hormone pathway, reduced body weight mainly through fat loss w…
Read article
TL;DR: A 2026 study in Stigma and Health found that women who lost 15% of body weight with GLP-1 receptor agonists, medications such as semaglutide that mimic a metabolic hormone involved in appetite and glucose signaling, were judged more harshly than women w…
Read article
Researchers have uncovered novel details about a specific population of brain cells that regulate obesity. Their findings provide increased understanding of the intricate neural circuits controlling energy balance and point to potential new therapeutic targets…
Read article